Spain Neurology Devices Market: Market Size & Forecast 2026

The Spanish neurology devices market covers a wide spectrum of products, including implantable neuromodulation systems, interventional neuroradiology equipment, neurosurgical instruments, hydrocephalus shunts, and neurological diagnostic and monitoring devices such as electroencephalography (EEG) and intracranial pressure (ICP) monitoring systems. Spain ranks as one of the leading neurology device markets in Western Europe, driven by its advanced public healthcare infrastructure and significant private sector investment in neurosciences. The market benefits from strong clinical research activity and a growing network of specialized neurology centers across the country.

• •Market valued at approximately $12.5 billion in 2025, with projected growth through 2030 and beyond
• •Covers devices spanning neuromodulation, interventional neuroradiology, neurosurgery, hydrocephalus management, and diagnostic monitoring
• •Supported by Spain's universal healthcare system and a mature medical device regulatory pathway

Spain's aging demographic profile is a primary catalyst, as neurological disorders such as stroke, Alzheimer's disease, and movement disorders disproportionately affect older populations. Rising disease prevalence is compounded by improving diagnostic capabilities, enabling earlier detection and intervention. Additional growth is fueled by Spain's commitment to healthcare modernization, increasing budgets for neurosciences, and expanding access to advanced neurointerventional procedures in both public and private hospitals.

• •Elevated incidence of age-related neurological conditions including cerebrovascular disease and neurodegenerative disorders
• •Growing adoption of minimally invasive neurointerventional procedures and advanced imaging-guided surgical techniques
• •Continued expansion of hospital infrastructure and specialized neuro-care centers across Spain's autonomous communities

The market is segmented across several device categories, including implantable and non-invasive neuromodulation devices, neurovascular embolization and accessory devices, intracranial stents, hydrocephalus shunts, neurosurgical products, and diagnostic equipment for electrical activity testing and ICP monitoring. Interventional neuroradiology has emerged as a particularly dynamic segment, driven by the rising prevalence of aneurysms and ischemic strokes. Geographically, major demand is concentrated in Madrid, Catalonia, and Andalusia, where leading hospital networks and research institutions are headquartered.

• •Key device categories include implantable neuromodulators, neurovascular embolization systems, intracranial stents, and hydrocephalus shunts
• •Diagnostic and monitoring segments cover electrical activity testing and intracranial pressure monitoring devices
• •Regional demand is highest in Madrid and Catalonia, supported by dense concentrations of tertiary care hospitals

What are the recent trends and outlook?

The market is positioned for sustained expansion through 2033, supported by ongoing clinical adoption of robot-assisted neurosurgery, advanced neuromodulation platforms, and AI-enhanced diagnostic imaging tools. Rising patient awareness and physician preference for minimally invasive neurovascular procedures will further drive segment growth. Spain's strong pharmaceutical and medtech ecosystem, combined with favorable reimbursement policies for selected neuro-devices, is expected to sustain annual growth rates above 7% over the forecast horizon.

• •Increasing integration of robotics and AI in neurosurgical planning and execution
• •Expanding use of bioresorbable materials and next-generation drug-eluting neurovascular implants
• •Growing tele-neurology and remote monitoring capabilities to support post-procedural care and chronic disease management